Dr. Merrill is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Boston, MA 02215Phone+1 617-667-7000
Education & Training
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2018 - 2021
- Tufts University School of MedicineClass of 2018
Certifications & Licensure
- CA State Medical License 2024 - 2026
- MA State Medical License 2018 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A phase-2 study of pembrolizumab in patients with biologically selected subtypes of relapsed/refractory aggressive lymphomas.Mwanasha H Merrill, Robert A Redd, David C Fisher, Jeremy S Abramson, Jeffrey Barnes
Leukemia & Lymphoma. 2025-03-25 - 1 citationsGlobal outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium.Jessy Xinyi Han, Min Jung Koh, Leora Boussi, Mark Sorial, Sean M McCabe
Blood Advances. 2025-02-11 - Detection of Maternal Malignancy After Abnormal Noninvasive Prenatal Testing: A Single-Center Case Series.Mwanasha H Merrill, Sophie R Cahill, Hannah W Pepprock, Robert Redd, Huma Q Rana
JCO Precision Oncology. 2024-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: